Raymond James Financial Services Advisors’s PDS Biotechnology PDSB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-11,154
| Closed | -$56.3K | – | 3371 |
|
|
2023
Q3 | $56.3K | Buy |
+11,154
| New | +$56.3K | ﹤0.01% | 3127 |
|
|
2023
Q2 | – | Sell |
-25,918
| Closed | -$159K | – | 3318 |
|
|
2023
Q1 | $159K | Buy |
+25,918
| New | +$159K | ﹤0.01% | 2961 |
|
|
2019
Q1 | – | Sell |
-7,923
| Closed | -$51K | – | 2809 |
|
|
2018
Q4 | $51K | Hold |
7,923
| – | – | ﹤0.01% | 2462 |
|
|
2018
Q3 | $130K | Hold |
7,923
| – | – | ﹤0.01% | 2620 |
|
|
2018
Q2 | $163K | Buy |
+7,923
| New | +$163K | ﹤0.01% | 2526 |
|
|
2018
Q1 | – | Sell |
-2,250
| Closed | -$422K | – | 2638 |
|
|
2017
Q4 | $422K | Hold |
2,250
| – | – | ﹤0.01% | 1805 |
|
|
2017
Q3 | $483K | Sell |
2,250
-150
| -6% | -$32.2K | ﹤0.01% | 1733 |
|
|
2017
Q2 | $492K | Hold |
2,400
| – | – | ﹤0.01% | 1682 |
|
|
2017
Q1 | $437K | Buy |
2,400
+50
| +2% | +$9.1K | ﹤0.01% | 1666 |
|
|
2016
Q4 | $588K | Hold |
2,350
| – | – | ﹤0.01% | 1439 |
|
|
2016
Q3 | $489K | Buy |
2,350
+50
| +2% | +$10.4K | ﹤0.01% | 1510 |
|
|
2016
Q2 | $465K | Hold |
2,300
| – | – | ﹤0.01% | 1462 |
|
|
2016
Q1 | $421K | Buy |
+2,300
| New | +$421K | ﹤0.01% | 1351 |
|